BOLD vs FTNT · P/E 0.1, $24.6M cap vs P/E 56, rev $6.80B
Boundless Bio, Inc. Common Stock (BOLD) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
BOLD does not have a complete income-statement cache yet.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the BOLD and FTNT stock pages for the full models.
Not investment advice.